Geode Capital Management’s Upstream Bio Inc UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.56M Buy
950,617
+98,709
+12% +$1.78M ﹤0.01% 2466
2025
Q4
$23.1M Buy
851,908
+34,799
+4% +$866K ﹤0.01% 1923
2025
Q3
$15.4M Buy
817,109
+170,474
+26% +$2.65M ﹤0.01% 2152
2025
Q2
$7.1M Buy
646,635
+235,958
+57% +$2.18M ﹤0.01% 2552
2025
Q1
$2.51M Buy
410,677
+47,408
+13% +$453K ﹤0.01% 2955
2024
Q4
$5.97M Buy
+363,269
New +$8.11M ﹤0.01% 2658

Other funds holding UPB

Geode Capital Management's UPB Position: Q1 2026 in Review

Geode Capital Management increased its Upstream Bio Inc (UPB) stake by 12% in Q1 2026, buying an estimated $1.78M and bringing the position to 950,617 shares worth $8.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2466.

Geode Capital Management first reported a position in UPB in Q4 2024 and has held it in 6 quarters since. The position peaked at $23.1M in Q4 2025. 140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • Geode Capital Management held 950,617 shares of Upstream Bio Inc worth $8.56M as of Q1 2026.
  • Geode Capital Management bought 98,709 Upstream Bio Inc shares in Q1 2026, an estimated $1.78M.
  • Upstream Bio Inc made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2466 holding.
  • Geode Capital Management first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 6 quarters since.
  • Geode Capital Management's Upstream Bio Inc position peaked at $23.1M in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.